Clinical Trial Update: Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN) [Phase 2]

View source ↗

Summary

A Phase 2 study investigating a potential new treatment for toxic epidermal necrolysis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Toxic Epidermal Necrolysis

Snippet

Sponsor: Loyola University | Conditions: Toxic Epidermal Necrolysis | Phase 2 | Status: WITHDRAWN